Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ILMN
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Illumina, Inc. (ILMN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Illumina (ILMN) trades at $211.06, down 3.28% today but maintains strong technical momentum with bullish moving averages and key support at $208. The company demonstrates robust fundamentals with consistent earnings beats, including Q2 2026 EPS of $1.31 beating estimates of $1.23, and improved profitability with 2025 net income margin of 19.57%. Recent S&P 500 inclusion announcement and positive analyst upgrades reflect growing institutional confidence.
ILMN presents a compelling growth story with strong earnings momentum and improving cash flow, though elevated valuation multiples (P/E 40.71) and competitive pressures in genomics remain key considerations. Analyst consensus leans bullish with 51% buy ratings and $204.15 price target, suggesting moderate upside potential from current levels with execution-dependent risk-reward profile.
Read full analysis

Key Stats

  • Market Cap
    $31.87B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $227.69
  • 52W Low
    $91.00
  • Typical Hold Time
    -
  • Enterprise Value
    $33.23B
  • Div Yield
    -
  • Trading Activity
    -
$205.66
52W Low: $91
14 Oct 2025
52W High: $227.69
27 Aug 2026

Track Illumina, Inc. (ILMN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Illumina, Inc. has traded between a low of $91 and a high of $227.69, highlighting its annual price range. Buy and sell Illumina, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Most Recent News

Content is generated by Aura AI

Chewy doubles earnings estimates with $0.36 EPS and raises sales guidance, boosting stock.

Chewy reported quarterly earnings of $0.36 per share, doubling analyst estimates of $0.18, with net income rising to $80.5 million from $62 million a year ago. Quarterly revenue reached $3.33 billion, slightly above expectations, marking a 7.3% incre...

Company Fundamentals
1 hour ago
Danny Green
Bullish
news icon
Chewy doubles earnings estimates with $0.36 EPS and raises sales guidance, boosting stock.

GMG's fast-charging GCELLS show no performance loss after 489 six-minute charge cycles.

Graphene Manufacturing Group Ltd (GMG) announced that its fast-charging GCELLS battery cells maintained full performance after 489 charge cycles, each completed within six minutes. This was demonstrated in tests conducted by the Battery Innovation Ce...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
GMG's fast-charging GCELLS show no performance loss after 489 six-minute charge cycles.

Class action lawsuit filed against Beta Bionics over alleged misleading claims about insulin pump safety.

Beta Bionics faces a class action lawsuit alleging it misled investors about the safety and regulatory status of its iLet Bionic Pancreas insulin pump. The lawsuit claims the company downplayed FDA concerns related to its manufacturing quality and fa...

Market News
4 hours ago
Newsfile Corp
Bearish
news icon
Class action lawsuit filed against Beta Bionics over alleged misleading claims about insulin pump safety.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $31.87B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $227.69
  • 52W Low
    $91.00
  • Typical Hold Time
    -
  • Enterprise Value
    $33.23B
  • Div Yield
    -
  • Trading Activity
    -
$205.66
52W Low: $91
14 Oct 2025
52W High: $227.69
27 Aug 2026

Track Illumina, Inc. (ILMN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Illumina, Inc. has traded between a low of $91 and a high of $227.69, highlighting its annual price range. Buy and sell Illumina, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!